Back
Oramed Pharmaceuticals Stock Predictions

Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Sell
33
ORMP
Oramed Pharmaceuticals
Last Price:
$2.14
Seasonality Move:
6.38%
7 Day Trial
ALL ACCESS PASS
$
7

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatioOramed Pharmaceuticals Stock Forecast
-
Is Oramed Pharmaceuticals Stock Undervalued?The current Oramed Pharmaceuticals [ORMP] share price is $2.15. The Score for ORMP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ORMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Oramed Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Oramed Pharmaceuticals Stock Rating
Data Unavailable
Oramed Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
oramed.com
52-Week Data
52-Week High:
3.09
52-Week Low:
1.82
Prediction Charts
Market Cap:
87.8M
Price in USD:
2.15
Volume:
36.9K
Beta:
0.27
Technical Analysis
SMA50:
2.24
SMA100:
2.27
SMA200:
2.33
52-Wk Change:
-6.52%
Stock Predictions
-
Is Oramed Pharmaceuticals stock public?Yes, Oramed Pharmaceuticals is a publicly traded company.
-
What is the Oramed Pharmaceuticals stock quote today?The Oramed Pharmaceuticals stock price is 2.15 USD today.
-
How to buy Oramed Pharmaceuticals stock online?You can buy Oramed Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-5 | 2.34 | 2.31 | 2.34 | 2.28 |
May-6 | 2.32 | 2.23 | 2.33 | 2.22 |
May-7 | 2.24 | 2.22 | 2.27 | 2.22 |
May-8 | 2.22 | 2.29 | 2.35 | 2.21 |
May-9 | 2.40 | 2.25 | 2.43 | 2.25 |
May-12 | 2.28 | 2.24 | 2.35 | 2.19 |
May-13 | 2.22 | 2.24 | 2.28 | 2.22 |
May-14 | 2.26 | 2.21 | 2.30 | 2.21 |
May-15 | 2.21 | 2.20 | 2.24 | 2.16 |
May-16 | 2.20 | 2.15 | 2.29 | 2.09 |
May-19 | 2.13 | 2.14 | 2.19 | 2.11 |
May-20 | 2.15 | 2.15 | 2.19 | 2.09 |
May-21 | 2.14 | 2.11 | 2.19 | 2.11 |
May-22 | 2.11 | 2.15 | 2.15 | 2.11 |
Oramed Pharmaceuticals Earnings
Data Unavailable
Oramed Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.43 per share, and a decrease next year of $0.00 per share.
* Oramed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.